Ching Natasha S, Kotsanas Despina, Easton Mee L, Francis Michelle J, Korman Tony M, Buttery Jim P
Department of Infection and Immunity, Monash Children's Hospital, Monash Health, Melbourne, Victoria, Australia.
Department of Paediatrics, The Ritchie Centre, Hudson Institute of Medical Research, Monash University, Melbourne, Victoria, Australia.
J Paediatr Child Health. 2018 Dec;54(12):1321-1328. doi: 10.1111/jpc.14076. Epub 2018 Jun 6.
This hospital network-based retrospective observational study aimed to describe the prevalence and seasonality of paediatric and adult viral respiratory pathogens and their rates of co-infections, following the introduction of a rapid multiplex molecular diagnostic assay.
All nasopharyngeal samples tested in patients presenting to Monash Health, Melbourne, Australia, from August 2009 to July 2015 by means of multiplex tandem polymerase chain reaction using the Respiratory Pathogen 12Plex kit (AusDiagnostics) were included in the analysis.
There were 28 729 patient samples analysed after duplicate samples were excluded. Positive results were twice as likely in paediatrics, 7573/11 491 (65.9%), compared to adults, 5410/17 238 (31.4%). Co-infection was more frequent in paediatrics, 1642/7573 (21.7% of positives), compared to adults 299/5410 (5.5%). Adenovirus had a high prevalence as a co-infection, 639/990 (64.5%), in paediatrics. Testing frequency increased by 179% in the paediatric group and by 949% for adults over the 6 years of observation.
This study demonstrated a significant difference in the positive detection rate of pathogens and co-infections between the population groups. Adenovirus had a surprisingly high prevalence as a co-infection, especially in paediatric patients. Over the study period, rapid uptake of the test was observed, especially in adults. This raises concerns about how we can ensure that testing remains rational and is able to be provided in a cost-effective manner in the future.
这项基于医院网络的回顾性观察性研究旨在描述在引入快速多重分子诊断检测方法后,儿童和成人病毒性呼吸道病原体的流行情况、季节性及其合并感染率。
纳入2009年8月至2015年7月在澳大利亚墨尔本莫纳什健康中心就诊的患者,使用呼吸道病原体12重试剂盒(AusDiagnostics)通过多重串联聚合酶链反应检测的所有鼻咽样本进行分析。
排除重复样本后,共分析了28729份患者样本。儿科患者的阳性结果可能性是成人的两倍,儿科为7573/11491(65.9%),而成人为5410/17238(31.4%)。儿科患者的合并感染更为常见,为1642/7573(占阳性的21.7%),而成人为299/5410(5.5%)。在儿科患者中,腺病毒作为合并感染的患病率很高,为639/990(64.5%)。在6年的观察期内,儿科组的检测频率增加了179%,成人组增加了949%。
本研究表明不同人群组在病原体和合并感染的阳性检出率方面存在显著差异。腺病毒作为合并感染的患病率出奇地高,尤其是在儿科患者中。在研究期间,观察到该检测方法的快速采用,尤其是在成人中。这引发了人们对于如何确保检测保持合理且能够在未来以具有成本效益的方式提供的担忧。